Literature DB >> 16242332

Staphylococcal innate immune evasion.

Suzan H M Rooijakkers1, Kok P M van Kessel, Jos A G van Strijp.   

Abstract

Upon entering the human body, bacteria are confronted with the sophisticated innate defense mechanisms of the human host. From work in recent years it has become obvious that a new and growing family of small and excreted proteins can counteract the antibacterial effects of innate immunity. These highly selective proteins pick out crucial elements of our immune system and inhibit their function. In Staphylococcus aureus these proteins act on specific cellular receptors, on antimicrobial peptides and especially on the complement system. The combined action of this growing group of essential virulence factors ascertains efficient innate immune evasion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16242332     DOI: 10.1016/j.tim.2005.10.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  97 in total

1.  A biosynthetic strategy for re-engineering the Staphylococcus aureus cell wall with non-native small molecules.

Authors:  James W Nelson; Alexander G Chamessian; Patrick J McEnaney; Ryan P Murelli; Barbara I Kazmierczak; Barbara I Kazmiercak; David A Spiegel
Journal:  ACS Chem Biol       Date:  2010-10-05       Impact factor: 5.100

2.  Molecular mechanisms of complement evasion: learning from staphylococci and meningococci.

Authors:  Davide Serruto; Rino Rappuoli; Maria Scarselli; Piet Gros; Jos A G van Strijp
Journal:  Nat Rev Microbiol       Date:  2010-06       Impact factor: 60.633

3.  Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein.

Authors:  Ilse Jongerius; Brandon L Garcia; Brian V Geisbrecht; Jos A G van Strijp; Suzan H M Rooijakkers
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

4.  Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion.

Authors:  Takahiro Shimada; Bong Goo Park; Andrea J Wolf; Constantinos Brikos; Helen S Goodridge; Courtney A Becker; Christopher N Reyes; Edward A Miao; Alan Aderem; Friedrich Götz; George Y Liu; David M Underhill
Journal:  Cell Host Microbe       Date:  2010-01-21       Impact factor: 21.023

5.  Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA.

Authors:  Diego O Andrey; Adriana Renzoni; Antoinette Monod; Daniel P Lew; Ambrose L Cheung; William L Kelley
Journal:  J Bacteriol       Date:  2010-09-24       Impact factor: 3.490

6.  Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.

Authors:  Eric L Brown; Yasuhiro Nishiyama; Jesse W Dunkle; Shreya Aggarwal; Stephanie Planque; Kenji Watanabe; Keri Csencsits-Smith; M Gabriela Bowden; Sheldon L Kaplan; Sudhir Paul
Journal:  J Biol Chem       Date:  2012-02-02       Impact factor: 5.157

7.  Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome.

Authors:  Hatice Karauzum; Gang Chen; Laura Abaandou; Mahta Mahmoudieh; Atefeh R Boroun; Sergey Shulenin; V Sathya Devi; Eric Stavale; Kelly L Warfield; Larry Zeitlin; Chad J Roy; Sachdev S Sidhu; M Javad Aman
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 8.  Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments.

Authors:  Sana S Dastgheyb; Michael Otto
Journal:  Future Microbiol       Date:  2015-11-19       Impact factor: 3.165

Review 9.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

Review 10.  Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.

Authors:  Min-Ho Kim
Journal:  IEEE Trans Nanobioscience       Date:  2016-03-02       Impact factor: 2.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.